Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-056424
Filing Date
2011-10-04
Accepted
2011-10-04 21:17:38
Documents
1
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v236548_4.html 4  
1 OWNERSHIP DOCUMENT v236548_4.xml 4 3634
  Complete submission text file 0001144204-11-056424.txt   5127
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXMED, INC. 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address
Oppenheim Leonard A (Reporting) CIK: 0001307647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 111125554